Alona Kashanian, DPM
Sports Medicine · Los Angeles, CANPI 1104998434
Payments from drug & device makers
Across 52 payments — averaging $34.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$355
- Saxum Surgical, Inc.$293
- Paragon 28, Inc.$185
- Stryker$136
- Organogenesis Inc.$124
- Biocomposites Inc$112
- plus $611 from 14 others
What the payments were for
- Food & beverage$1,816100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 10 | $355 |
| Saxum Surgical, Inc. | 2 | $293 |
| Paragon 28, Inc. | 2 | $185 |
| Stryker | 3 | $136 |
| Organogenesis Inc. | 3 | $124 |
| Biocomposites Inc | 1 | $112 |
| Amgen | 6 | $98 |
| Averitas Pharma Inc. | 4 | $88 |
| Biotissue Holdings Inc. | 3 | $64 |
| Integra Lifesciences Corporation | 2 | $56 |
| Sebela Pharmaceuticals Inc. | 3 | $50 |
| Medtronic | 2 | $45 |
| Johnson & Johnson | 1 | $43 |
| Sandoz | 2 | $41 |
| Paratek Pharmaceuticals, Inc. | 2 | $35 |
| Tactile Systems Technology Inc | 2 | $27 |
| Alfasigma USA, Inc. | 1 | $19 |
| Merck | 1 | $18 |
| Kowa Pharmaceuticals America, Inc. | 1 | $16 |
| Lifenet Health | 1 | $9 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,816 in reported general payments places this provider in the 50th percentile of 662 sports medicine providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ketoconazole | 846 | $20,253 |
| Gabapentin | 333 | $3,473 |
| Diclofenac Sodium | 113 | $2,650 |
| Econazole Nitrate | 44 | $2,252 |
| Clobetasol Propionate | 50 | $1,974 |
| Mupirocin | 182 | $1,070 |
| Ammonium Lactate | 67 | $816 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 73 | $550 |
| Terbinafine Hcl | 25 | $524 |
| Pregabalin | 21 | $399 |
| Meloxicam | 116 | $384 |
| SsdSilver Sulfadiazine | 38 | $308 |
| Ciclopirox | 20 | $246 |
| Doxycycline Hyclate | 20 | $232 |
| Allopurinol | 24 | $215 |
Paid to pharmacies, not to this prescriber.
Other sports medicine in Los Angeles
- Neal ElattracheLos Angeles$51M
- Carleton VangsnessLos Angeles$872K
- Kristofer JonesLos Angeles$605K
- Michael BanffyLos Angeles$578K
- Seth GamradtLos Angeles$567K
- Reza OmidLos Angeles$400K
- Orr LimpisvastiLos Angeles$335K
- George HatchLos Angeles$255K
- David McAllisterLos Angeles$186K
- Stephen LiuLos Angeles$169K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.